A Novel Four‑snoRNA Signature for Predicting the Survival of Patients With Uveal Melanoma

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2018.9766
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

A Four-Long Non-Coding RNA Signature in Predicting Breast Cancer Survival

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

A Four-Long Non-Coding RNA Signature in Predicting Breast Cancer Survival

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Changes in microRNA Expression Associated With Metastasis and Survival in Patients With Uveal Melanoma

Oncotarget
Oncology
2020English

Does Ocular Treatment of Uveal Melanoma Influence Survival?

British Journal of Cancer
Cancer ResearchOncology
2010English

Uveal Melanoma Cells Utilize a Novel Route for Transendothelial Migration

PLoS ONE
Multidisciplinary
2014English

Survival of Patients With Advanced Metastatic Melanoma: The Impact of Novel Therapies

European Journal of Cancer
Cancer ResearchOncology
2016English

High Expression of lncRNA PVT1 Independently Predicts Poor Overall Survival in Patients With Primary Uveal Melanoma

PLoS ONE
Multidisciplinary
2017English

Endoresection With Adjuvant Ruthenium Brachytherapy for Selected Uveal Melanoma Patients - The Tuebingen Experience

Acta Ophthalmologica
MedicineOphthalmology
2016English

Uveal Melanoma Survival Rates After Single Dose Stereotactic Radiosurgery

Neoplasma
Cancer Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy